A carregar...
Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
Drug resistance limits the clinical efficacy of breast cancer therapies, and overexpression or activation of Yes‐associated protein (YAP) is common in drug‐resistant cancer cells. Thus, inhibition of YAP may reduce resistance to anti‐cancer drugs. Metformin (MET), a first‐line diabetes medication th...
Na minha lista:
| Publicado no: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214175/ https://ncbi.nlm.nih.gov/pubmed/32281270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15241 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|